propylene glycol has been researched along with melphalan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aljitawi, OS; Allen, LF; Arce-Lara, C; Bhat, G; Callander, N; Hari, P; Nath, R; Stockerl-Goldstein, K | 1 |
| Bergren, M; Chen, J; Mallik, R; Miller, T; Singh, R | 1 |
| Badar, T; Chhabra, S; D'Souza, A; Dhakal, B; Drobyski, WR; Fenske, TS; Hamadani, M; Hari, P; Pasquini, M; Saber, W; Shah, NN; Shaw, BE | 1 |
| Glotzbecker, B; Laubach, J; McDonnell, AM; Ni, J; Soiffer, R; Xiang, E | 1 |
1 trial(s) available for propylene glycol and melphalan
| Article | Year |
|---|---|
A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.
Topics: Adult; Aged; Cyclodextrins; Drug Administration Schedule; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Mucositis; Multiple Myeloma; Myeloablative Agonists; Propylene Glycol; Severity of Illness Index; Solubility; Stomatitis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2015 |
3 other study(ies) available for propylene glycol and melphalan
| Article | Year |
|---|---|
Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection.
Topics: Antineoplastic Agents, Alkylating; beta-Cyclodextrins; Drug Contamination; Drug Stability; Excipients; Injections; Melphalan; Pharmaceutical Solutions; Propylene Glycol | 2018 |
Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective.
Topics: Adult; Aged; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Melphalan; Middle Aged; Propylene Glycol; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2018 |
Evaluating the adverse effects of melphalan formulations.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Cohort Studies; Drug Compounding; Drug-Related Side Effects and Adverse Reactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Propylene Glycol; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2019 |